People · Operator
Named in public records as an officer, director or promoter · active 2014–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Precipio, Inc. | — | Biotechnology | Series B | $67.0M | $32.2M | 2014 |
Michael A. Luther at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael A. Luther on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Cohen | 1 | 38 |
| Antonius Schuh | 1 | 5 |
| Rodney Markin | 1 | 4 |
| Michael Luther | 1 | 4 |
| Doug Fisher | 1 | 3 |
| RODNEY S MARKIN | 1 | 3 |
| Mark Rimer | 1 | 2 |
| MARK P. COLONNESE | 1 | 2 |
| John D. Thompson | 1 | 2 |
| Ilan Danieli | 1 | 2 |
| Carl Iberger | 1 | 2 |
| CHAD M RICHARDS | 1 | 1 |
| BRETT L FREVERT | 1 | 1 |
| DOIT J KOPPLER II | 1 | 1 |
| BRETT J FREVERT | 1 | 1 |
| CHAD J RICHARDS | 1 | 1 |
| ROBERT J PATZIG | 1 | 1 |
| RODNEY J MARKIN | 1 | 1 |
| ANTONIUS J SCHUH | 1 | 1 |
| Paul Kinnon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.